Chinnadurai, Rajkumar
Huckle, Abby
Hegarty, Janet
Kalra, Philip A
Sinha, Smeeta http://orcid.org/0000-0003-4117-4085
Funding for this research was provided by:
Amgen Foundation
University of Manchester
Article History
Received: 12 September 2020
Accepted: 10 November 2020
First Online: 6 February 2021
Compliance with Ethical Standards
:
: SS has received speaker fees and consultancy fees from Vifor Pharma and Napp pharmaceuticals and consultancy fees from Sanifit pharmaceuticals. SS is also the principle investigator for the UK Calciphylaxis study. No disclosures from the other authors.
: The CRISIS-HD adhered to the Declaration of Helsinki and has ethical approval for all observational data (REC 05/Q1404/188). The UK Calciphylaxis study gained ethical approval from the National Research Ethics Service (reference: 11/NW/0528).